This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Barry A Katz: Innovator in Cancer Treatment
Introduction
Barry A Katz is a notable inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic compounds. His work focuses on inhibiting farnesyl-protein transferase, a crucial enzyme involved in cancer progression.
Latest Patents
Barry A Katz holds 1 patent for his invention titled "Inhibitors of farnesyl-protein transferase." This patent is directed towards compounds that inhibit farnesyl-protein transferase (FPTase) and the farnesylation of the oncogene protein Ras. The invention also encompasses chemotherapeutic compositions containing these compounds and methods for effectively inhibiting FPTase and the farnesylation process.
Career Highlights
Barry A Katz is associated with Merck & Co., Inc., a leading global healthcare company. His role at Merck has allowed him to contribute to groundbreaking research in the pharmaceutical industry, particularly in the development of cancer therapies.
Collaborations
Throughout his career, Barry has collaborated with esteemed colleagues, including Isabel Martin and Russell B Lingham. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Barry A Katz's work exemplifies the impact of innovative research in the fight against cancer. His contributions to the development of farnesyl-protein transferase inhibitors represent a significant advancement in therapeutic options for patients.